Press Release: Global Blood Therapeutics Inc : GBT Announces Participation at the Wedbush PacGrow Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the Wedbush PacGrow Healthcare Conference on Wednesday, August 10, 2022, at 2:20 p.m. E.T.
Read full article »
GBT is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of sickle cell diseases.
Read more